Siemens Healthineers has signed a five-year strategic partnership agreement with The Ohio State University Wexner Medical Center to advance personalised medicine and improve access to high quality, low-cost healthcare.
Under the partnership deal, Siemens Healthineers and its subsidiary Varian will provide advanced imaging and treatment technologies for an upcoming outpatient expansion of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The partnership will provide radiation oncology modalities and advanced imaging technology at the Outpatient Care West Campus to provide AI-driven personalised care solutions for patients.
Through the development of advanced imaging methods, the partnership will help in improving access to care for claustrophobic and obese patients.
The collaboration also expands next-generation vascular robotics capabilities with an aim to provide better access to advanced treatments across Ohio.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The advanced precision cancer care in the new outpatient centre, which is planned to open in 2023, will feature Edge radiosurgery system, ProBeam 360° proton therapy along with oncology-focused Artis Q Ceiling interventional radiology system.
The West Campus will include Biograph Vision 600 Digital PET system and Somatom Drive and Somatom Force dual source dual energy CT scanners.
Furthermore, Siemens Healthineers will provide new technology to Ohio State’s new inpatient hospital, which is planned to open in 2026.
Three other outpatient facilities in Dublin, New Albany, and Powell will also benefit from the new technology.
The Ohio State University research vice-president and Wexner Medical Center chief scientific officer Peter Mohler said: “This work not only supports a key step in our mission to improve the lives of our patients, but together we will research ways technology can accelerate breakthrough health discoveries and the care delivery process for all patients in the future.”
Siemens and OSUCC – James researchers will explore opportunities in radiation dosimetric contouring algorithms which are tailored to the individual patients.
They will also develop a platform that combines artificial intelligence (AI) with clinical, imaging, pathology, and genomic data to drive pathways of care in nearly real time.